Indian pharmaceutical company Mankind Pharma announced its entry into the US market with an investment of Rs.300 crore.
“We wish to become a multi-national pharma company by tapping the foreign markets. We aim to place ourselves amongst the top three pharmaceutical companies of India. The US market will come up with new innovative products which will further distinguish us from others,” Mankind Pharma chairman and founder R.C. Juneja said in a statement.
Aiming for a revenue of Rs.1,000 crore from the international market by 2030, Mankind Pharma is focusing on implementing the same affordable healthcare strategy in the US as in India, the statement said.
Founded in 1995, Mankind Pharma currently employs more than 12,000 people, and has a turnover of around Rs.5,000 crore.